KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Fulgent Genetics (FLGT) over the last 10 years, with Q3 2025 value amounting to -$445000.0.

  • Fulgent Genetics' Cash from Financing Activities rose 2151.68% to -$445000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.6 million, marking a year-over-year increase of 5214.47%. This contributed to the annual value of -$4.8 million for FY2024, which is 8985.66% up from last year.
  • As of Q3 2025, Fulgent Genetics' Cash from Financing Activities stood at -$445000.0, which was up 2151.68% from -$2.6 million recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Cash from Financing Activities ranged from a high of $47.3 million in Q1 2021 and a low of -$35.5 million during Q3 2022
  • For the 5-year period, Fulgent Genetics' Cash from Financing Activities averaged around -$3.1 million, with its median value being -$2.6 million (2025).
  • In the last 5 years, Fulgent Genetics' Cash from Financing Activities skyrocketed by 4737627.12% in 2021 and then tumbled by 108641.69% in 2022.
  • Fulgent Genetics' Cash from Financing Activities (Quarter) stood at $13.2 million in 2021, then plummeted by 324.97% to -$29.6 million in 2022, then rose by 12.31% to -$26.0 million in 2023, then surged by 98.74% to -$327000.0 in 2024, then plummeted by 36.09% to -$445000.0 in 2025.
  • Its last three reported values are -$445000.0 in Q3 2025, -$2.6 million for Q2 2025, and -$11.2 million during Q1 2025.